Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study
NAGIOS: RODERIC FUNCIONANDO

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

DSpace Repository

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Show full item record

View       (113.6Kb)

    
Grill, Jacques; Geoerger, Birgit; Gesner, Lyle; Perek, Danuta; Leblond, Pierre; Cañete Nieto, Adela; Aerts, Isabelle; Madero, Luis; de Toledo Codina, Josep Sanchez; Verlooy, Joris; Estlin, Edward; Cisar, Laura; Breazna, Aurora; Dorman, Andrew; Bailey, Simon; Nicolin, Gary; Grundy, Richard G.; Hargrave, Darren
This document is a artículoDate2013

Este documento está disponible también en : http://hdl.handle.net/10550/44467

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

Statistics